Join us at Discovery Europe and network with us and over 400 industry leaders. We will be there to discuss the latest advancements in ultra-High Throughput Screening, Mass Spectrometry, ASMS, target identification, validation and HIT optimization.
The 2-day program addresses emerging strategies for drug development within Neuroscience and successful approaches for more targeted, precise, and transformative therapies to neurodegenerative and neuropsychiatric diseases.
Tuesday June 6th
Track 3: 09:20-09:50 AM
Dr. Saman Honarnejad
“Evaluating target engagement of a focused lead-like and pan-assay interference compound collection using affinity selection mass spectrometry”.
Will you meet us there? Schedule your appointment with our experts here directly!